Company Profile

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.

Employees

725

Sector

Medical Equipment, Supplies & Distribution

More about the company

27/09/23	Orbusneich Medical Group Holdings Limited and Cardiovascular Systems, Inc. Enters into an Amendment to Distribution Agreement	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P Healthcare Equipment Select Industry Index	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P Composite 1500	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P 600	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P Global BMI Index	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P 1000	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P TMI Index	CI
01/05/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from S&P 600 Health Care	CI
27/04/23	Cardiovascular Systems, Inc.(NasdaqGS:CSII) dropped from NASDAQ Composite Index	CI
27/04/23	Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. from The Vanguard Group, Inc. and others.	CI
10/02/23	Wall St dips as Treasury yields rise after auction	RE
10/02/23	Wall St dips as Treasury yields rise after auction	RE
10/02/23	Wall St dips as Treasury yields rise; Disney hits 5-month high	RE

21/12/22	Barclays Starts Cardiovascular Systems at Equalweight With $15 Price Target	MT
14/12/22	Lake Street Initiates Coverage on Cardiovascular Systems With Buy Rating, $25 Price Target	MT
05/05/22	SVB Leerink Adjusts Cardiovascular Systems' Price Target to $20 from $25, Keeps Outperform Rating	MT
04/02/22	SVB Leerink Adjusts Cardiovascular Systems Price Target to $20 From $25, Maintains Outperform Rating	MT
17/11/21	Needham Downgrades Cardiovascular Systems to Hold From Buy, Anticipating Another Miss/Guidance Reduction; $36 PT Removed	MT

28/04/23	CARDIOVASCULAR SYSTEMS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
13/04/23	Cardiovascular : The Nasdaq Stock Market LLC - Form 8-K	PU
13/04/23	CARDIOVASCULAR SYSTEMS INC : Other Events (form 8-K)	AQ
04/04/23	Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial	BU
29/03/23	CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII	BU

10/02/23	Point marchés-Wall Street finit en baisse sur fond de hausse des obligations
09/02/23	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Robert Ford CEO	Chief Executive Officer	52	01/04/2023
John McCoy PSD	President	56	-
Jeffery W. Chambers CTO	Chief Tech/Sci/R&D Officer	-	02/03/2022

Cardiovascular Systems, Inc. Stock

Stocks

CSII

US1416191062

Medical Equipment, Supplies & Distribution

Latest news : Cardiovascular Systems, Inc.

Analysts' recommendations: Cardiovascular Systems, Inc.

Press Releases: Cardiovascular Systems, Inc.

News in other languages: Cardiovascular Systems, Inc.

Quotes and Performance

Managers and Directors: Cardiovascular Systems, Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Company Profile

Director	Title	Age	Since
Augustine Lawlor BRD	Director/Board Member	69	01/02/2009
William Cohn BRD	Director/Board Member	66	27/02/2015
Robert Ford CHM	Chairman	52	01/04/2023

Date	Insider	Type	Main position	Quantity	% Market Cap.
27/04/23	Augustine Lawlor	Issuer sale	Director	134,059	0.3195%
27/04/23	Stephen Stenbeck	Issuer sale	Director	22,853	0.0545%
27/04/23	Jeffrey Points	Issuer sale	Chief Financial Officer	173,008	0.4123%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOVASCULAR SYSTEMS, INC.	+0.15%	+0.10%	-	-	844M
ABBOTT LABORATORIES	-0.69%	+3.25%	-28.63%	-10.50%	166B
MEDTRONIC PLC	-2.17%	+3.55%	-7.42%	-4.52%	105B
CENCORA, INC.	+1.67%	+7.33%	+3.87%	+62.20%	60.23B
HOYA CORPORATION	+3.64%	-3.17%	+43.86%	+54.63%	49.17B
BECTON, DICKINSON AND COMPANY	-3.67%	-1.53%	-13.78%	-41.40%	41.49B
MEDLINE INC.	-6.30%	-3.43%	-	-	34.08B
DEXCOM, INC.	+0.67%	+7.55%	-11.58%	-41.55%	28.58B
WEST PHARMACEUTICAL SERVICES, INC.	-0.67%	-3.10%	+60.41%	-4.82%	24.99B
TERUMO CORPORATION	-2.15%	+0.59%	-10.20%	+3.70%	20.64B
Average	-0.87%	+1.56%	+4.57%	+2.22%	58.88B
Weighted average by Cap.	-0.63%	+2.11%	-5.52%	+2.56%